Business
Investor Briefing
Investor Briefing.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 3122I Omega Diagnostics Group PLC 08 August 2019 \n\n \nOmega Diagnostics Group PLC\n(\"Omega\" or \"the Company\" or the \"Group\")\n \nInvestor briefing \n \nOmega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces it will be hosting an investor evening for all investors on Monday 19 August 2019, accompanying the full year results for the year ended 31 March 2019.\n \nThe event will take place in the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by light refreshments, and a chance to network.\n \nThe results presentation will be available on the Company website shortly after the event. No new information will be disclosed. \n \nIf you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected].\n \n \n \nContacts:\n \n\n\n\nOmega Diagnostics Group PLC \n\n\nTel: 01259 763 030\n\n\n\n\nBill Rhodes, Interim Non-Executive Chairman\n \n\n\nwww.omegadiagnostics.com\n\n\n\n\nColin King, Chief Executive \n\n\n \n\n\n\n\nKieron Harbinson, Group Finance Director\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nfinnCap Ltd \n\n\nTel: 020 7220 0500\n\n\n\n\nGeoff Nash/James Thompson/ Hannah Boros (Corporate Finance)\n\n\n\n\n\n\n\n...